Back

Inclisiran: a breakthrough in LDL-C reduction for indian ASCVD patients

31 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Risk factors and prevention Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Radha Yalamanchi

Apollo Main Hospitals, Chennai (India)

7 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Abstract Video
Presentation thumbnail
Associate Professor F. Guerra (Ancona, IT)
Abstract Video
Presentation thumbnail
Doctor P. Sobieraj (Warsaw, PL)
Abstract
Presentation thumbnail
Doctor M. Tan (London, GB)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Risk factors and prevention

The Event

Event poster

ESC Congress 2025

31 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
Lipid-lowering therapy with Inclisiran in the real-world setting: initial data from a national health care service
31 August 2024
thumbnail
Congress Presentation
Suboptimal LDL-C control despite high statin use: insights from the LAI-LCARE survey on secondary CAD prevention in India
29 August 2025
thumbnail
Congress Presentation
Efficacy and safety of Alirocumab once-monthly dosing in patients with atherosclerotic cardiovascular disease and without acute coronary syndrome or stroke; an ODYSSEY CHOICE I analysis
1 September 2025
thumbnail
Congress Presentation
Unmet needs of LDL C lowering in ACS patients when using only high intensity statins puts at setback
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources